Christine Ring serves as the Chief Legal Officer and Chief Compliance Officer at Nurix Therapeutics Inc., a biopharmaceutical company focused on developing novel therapies for cancer and other diseases. In her role, Christine is responsible for overseeing all legal matters and ensuring that the company adheres to regulatory standards and compliance requirements. Her strategic guidance is crucial in navigating the complex landscape of pharmaceutical development and commercialization. Prior to joining Nurix Therapeutics, Christine amassed extensive experience in the legal field, particularly within the life sciences industry. She held significant positions at several prominent companies, where she honed her expertise in corporate law, intellectual property, and regulatory compliance. Christine's career is marked by her ability to effectively manage legal risks while supporting business growth and innovation. Her contributions have been instrumental in guiding companies through mergers, acquisitions, and other strategic initiatives. Christine's achievements extend beyond her corporate roles; she is also recognized for her thought leadership and contributions to the legal community. She frequently speaks at industry conferences and has authored numerous articles on topics related to legal and compliance issues in the biopharmaceutical sector. Her dedication to fostering a culture of integrity and ethical conduct at Nurix Therapeutics has solidified her reputation as a respected leader in her field.